Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Change in Receivables (2016 - 2025)

AtriCure (ATRC) has disclosed Change in Receivables for 16 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 38.07% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.6 million, a 32.42% decrease, with the full-year FY2025 number at $5.6 million, down 32.42% from a year prior.
  • Change in Receivables was $3.8 million for Q4 2025 at AtriCure, up from -$3.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $8.0 million in Q1 2022 to a low of -$3.0 million in Q3 2025.
  • A 5-year average of $2.1 million and a median of $2.4 million in 2023 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: skyrocketed 23200.0% in 2023, then tumbled 234.71% in 2025.
  • AtriCure's Change in Receivables stood at -$496000.0 in 2021, then surged by 100.81% to $4000.0 in 2022, then surged by 23200.0% to $932000.0 in 2023, then soared by 550.54% to $6.1 million in 2024, then crashed by 38.07% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Change in Receivables are $3.8 million (Q4 2025), -$3.0 million (Q3 2025), and $2.2 million (Q2 2025).